Effect of medicaid expansion on breaches and record theft as defined by the privacy rights clearinghouse. by Jeffrey Clement (10515268)

Subjects:

Search strategy defined by population, concept, context framework, with Boolean operators. by Emily M. Jones (21989800)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Flow diagram illustrating the sequence of procedures executed during one time step defined as tick, each of which represents one week. by Alexandra M. Campbell (3284094)

Subjects:

Root Cause Analysis using 5 Whys: first, clearly define the problem that needs resolution. by Mohammad Bakhtiari (11838264)

Subjects:

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Details of included studies that measured patient impact. by Emily M. Jones (21989800)

Subjects:

Meropenem Consumption Across Quarters of 2022-2023: Defined Daily Dose (Blue Bars) and Antimicrobial Cost per Patient Day (Red Line). by Rawan T. Tafish (21736177)

Subjects:

Sociodemographic and clinical characteristics of patients. by Mark Mohan Kaggwa (11187247)

Subjects:

Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. by Hongliang Chen (538815)

Forest Plot of Multivariate Odds Ratios for Risk Factors Associated with Nerve Injury 90 Days After Total Knee Arthroplasty. by Rahul H. Jayaram (21463899)

Subjects:

Univariate and Multivariate analysis of risk factors for nerve injury 90-days after TKA. by Rahul H. Jayaram (21463899)

Subjects:

Patient flowchart. by Anna D. Ware (19688153)

Subjects:

Studies measuring patient-level impact (N = 6, 19% of included studies). by Emily M. Jones (21989800)

Subjects:

Enrichment of rare variants within top 100 genes with largest carrier statistic in Alzheimer’s disease patients. by Hanmin Guo (19762533)

“…<p>Genes were ranked according to decreasing order of carrier statistic. Fold enrichment was defined as the ratio of rare variants burden within the gene in case group compared to that in the control group.…”

Patient enrollment and inclusion information. by Ruitian Song (11045127)

Subjects:

Largest changes in influenza vaccine rates, Pre- vs. Post-COVID-19. by Tyler B. Nofzinger (21560244)

Subjects:

Studies measuring provider-level impact (N = 26, 81% of included studies). by Emily M. Jones (21989800)

Subjects:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart. by Emily M. Jones (21989800)

Subjects:

Study demographics of all included studies. by Emily M. Jones (21989800)

Subjects: